• 70078 Citations
1984 …2024
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

As Chair of an interdisciplinary Department of Medical Social Sciences, I play a leadership role in the development and orchestration of transdisciplinary scientific collaborations. Our department conducts basic and applied social science research to advance the understanding of the mechanisms and measurement of health and disease. I oversee all academic and research programs, financial operations, faculty affairs and program development of the department. In both my capacity as PI on multiple trans-NIH initiatives and as Chair, I play leadership roles in the development and orchestration of transdisciplinary scientific collaborations. As a measurement scientist with expertise in applied health status measurement, I have led the development of numerous item banks and instruments, intended for both normal and clinical populations including paper-and-pencil and computer administered instruments. I was the principal investigator of the trans-NIH NeuroQoL and the PROMIS Statistical Center. In the first cycle of PROMIS (2004-2009), I was PI of the Statistical Coordinating Center (SCC). Currently I am the PI of The National Person-Centered Assessment Resource (PCAR) grant and ECHO PRO CORE grant. A theme of my work has been ensuring that the voice of the patient is reflected in clinical care and clinical research, including areas of high-stakes decision-making such as regulatory review, payer negotiations, and individual clinical care. A major focus of many of these initiatives has been ensuring measurement sensitive to diverse populations including issues of health literacy and health disparities and developmentally-sensitive measurement across the lifespan.

Training Experience

1980Internship, Loyola University Counseling Center
1982Internship, Payne Whitney Psychiatric Clinic
1983Fellowship, Payne Whitney Psychiatric Clinic
1986Fellowship, Memorial Sloan-Kettering Cancer Center

Education/Academic qualification

PhD, Loyola University-Stritch School of Medicine

… → 1984

Research interests

  • Cancer Communications
  • Health Disparities
  • Outcome Measures
  • Outcome measures
  • Patient reported outcomes
  • Patient-Reported Outcomes
  • Psychological Issues of Patients Dealing with Medical Illness
  • Psychological issues of patients dealing with medical illness
  • Psychometrics
  • Quality of Life

Fingerprint Dive into the research topics where David Cella is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles
Quality of Life Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Fatigue Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Information Systems Medicine & Life Sciences
Health Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2001 2024

Lower Urinary Tract Symptoms
Urinary Tract
Research
Cluster Analysis
Mobile Applications
Outcome Assessment (Health Care)
Sarcopenia
Irritable Bowel Syndrome
Information Systems
Drug Approval
DDT
United States Food and Drug Administration
Information Systems
Outcome Assessment (Health Care)
Critical Pathways
Patient Outcome Assessment
Sarcopenia
United States Food and Drug Administration
Outcome Assessment (Health Care)
Clinical Trials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Patient Care
Protein-Tyrosine Kinases
Therapeutics
Physicians

Research Output 1984 2019

A new outcome measure for LUTS: Symptoms of Lower Urinary Tract Dysfunction Research Network Symptom Index-29 (LURN SI-29) questionnaire

the LURN Study Group, Aug 1 2019, In : Neurourology and Urodynamics. 38, 6, p. 1751-1759 9 p.

Research output: Contribution to journalArticle

Lower Urinary Tract Symptoms
Outcome Assessment (Health Care)
Urinary Tract
Statistical Factor Analysis
Research

A Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC)

Shah, R., Botteman, M., Solem, C. T., Luo, L., Doan, J., Cella, D. & Motzer, R. J., Jan 1 2019, In : Clinical Genitourinary Cancer.

Research output: Contribution to journalArticle

Open Access
Renal Cell Carcinoma
Survival
Everolimus
nivolumab
Patient Preference

Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome

Halperin, D. M., Huynh, L., Beaumont, J. L., Cai, B., Bhak, R. H., Narkhede, S., Totev, T., Duh, M. S., Neary, M. P. & Cella, D., Mar 28 2019, In : BMC cancer. 19, 1, 274.

Research output: Contribution to journalArticle

Open Access
Carcinoid Tumor
Somatostatin
Quality of Life
Delivery of Health Care
Information Systems
Quality of Life
Neoplasms
Therapeutics

Breast cancer survivors' preferences for mHealth physical activity interventions: findings from a mixed methods study

Phillips, S. M., Courneya, K. S., Welch, W. A., Gavin, K. L., Cottrell, A., Nielsen, A., Solk, P., Blanch-Hartigan, D., Cella, D., Ackermann, R. T., Spring, B. & Penedo, F., Apr 1 2019, In : Journal of cancer survivorship : research and practice. 13, 2, p. 292-305 14 p.

Research output: Contribution to journalArticle

Telemedicine
Survivors
Exercise
Breast Neoplasms
Interviews